ORGO - Organogenesis Holdings Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.21
|
Rev Est: $172.7M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.00
DETAILS
HIGH:
$9.00
LOW:
$9.00
MEDIAN:
$9.00
CONSENSUS:
$9.00
UPSIDE:
123.33%
Market Cap:
511.46M
Volume:
341,386
Avg Volume:
1,041,218
52 Week Range:
2.61-7.077
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
1.40
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
869
IPO Date:
2017-01-05
EPS (TTM):
0.01
P/E Ratio:
489.38
Revenue (TTM):
482.04M
Total Assets:
497.89M
Total Debt:
43.31M
Cash & Equiv:
135.57M
Rev Growth (5Y):
13.1%
EPS Growth (5Y):
-55.1%
FCF Growth (5Y):
N/A
ROCE:
-0.3%
Debt/Equity:
0.11
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.18 | $0.21 | -14.3% | $150.9M | $172.7M | -12.6% |
| 2025-08-07 | $-0.09 | $0.07 | -228.6% | $101.0M | $134.1M | -24.7% |
| 2025-05-08 | $-0.13 | $0.04 | -425.0% | $86.7M | $90.8M | -4.5% |
| 2025-02-27 | $0.04 | $-0.03 | +233.3% | $126.7M | $109.6M | +15.6% |
| 2024-11-12 | $0.09 | $0.01 | +700.0% | $115.2M | $106.9M | +7.7% |
| 2024-08-08 | $-0.13 | $-0.02 | -550.0% | $130.2M | $121.8M | +6.9% |
| 2024-05-09 | $-0.02 | $-0.02 | -25.0% | $110.0M | $101.0M | +8.8% |
| 2024-02-29 | $-0.00 | $-0.00 | -100.5% | $99.7M | $109.0M | -8.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 482.04M | 433.14M | 450.89M | 467.36M | 338.30M | 260.98M | 193.45M | 0 | 0 |
| Net Income | 861,000 | 4.95M | 15.53M | 94.20M | 17.23M | (38.71M) | (64.83M) | (2.09M) | (208,698) |
| EPS | 0.01 | 0.04 | 0.12 | 0.73 | 0.16 | -0.44 | -0.94 | -0.03 | -0.02 |
| Total Assets | 497.89M | 460.02M | 449.36M | 443.26M | 290.22M | 220.69M | 163.68M | 312.79M | 311.44M |
| Total Debt | 43.31M | 119.35M | 123.79M | 132.30M | 84.77M | 100.61M | 59.26M | 17.86M | 0 |
| Cash & Equivalents | 135.57M | 104.34M | 102.48M | 113.93M | 84.39M | 60.17M | 21.29M | 125,886 | 1.04M |
| Operating Cash Flow | 14.21M | 30.92M | 24.86M | 61.98M | 5.47M | (33.53M) | (60.74M) | (586,604) | (562,233) |
| Free Cash Flow | 4.18M | 6.55M | (9.04M) | 30.76M | (12.21M) | (39.76M) | (62.60M) | (3.01M) | (1.92M) |
| FCF per Share | 0.03 | 0.05 | -0.07 | 0.24 | -0.11 | -0.43 | -0.91 | -0.05 | -0.22 |
| Book Value | 385.32M | 278.66M | 265.67M | 241.34M | 141.81M | 55.58M | 47.04M | 298.01M | 300.11M |
| Cash & ST Investments | 135.57M | 104.34M | 102.48M | 113.93M | 84.39M | 60.17M | 21.29M | 125,886 | 1.04M |
| ROC Equity | 0.00 | 0.02 | 0.06 | 0.39 | 0.12 | -0.70 | -1.38 | -0.01 | -0.00 |